Net loss of Camlin Fine Sciences reported to Rs 77.14 crore in the quarter ended March 2024 as against net profit of Rs 9.16 crore during the previous quarter ended March 2023. Sales declined 5.86% to Rs 401.69 crore in the quarter ended March 2024 as against Rs 426.71 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 92.75 crore in the year ended March 2024 as against net profit of Rs 52.11 crore during the previous year ended March 2023. Sales declined 4.07% to Rs 1613.06 crore in the year ended March 2024 as against Rs 1681.56 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales401.69426.71 -6 1613.061681.56 -4 OPM %-3.3010.27 -4.5812.21 - PBDT-23.6636.04 PL 29.16152.57 -81 PBT-43.7118.11 PL -49.4490.06 PL NP-77.149.16 PL -92.7552.11 PL Powered by Capital Market - Live News

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 20 May 2024Powered by Capital Market - Live News

Camlin Fine Sciences has allotted 10,400 equity shares under ESOP on 15 March 2024. Consequently, the paid up equity share capital has increased to o 167465207 equity shares of face value of Re.1/�] each aggregating to Rs. 16,74,65,207/�]. Powered by Capital Market - Live News

Net loss of Camlin Fine Sciences reported to Rs 11.79 crore in the quarter ended December 2023 as against net profit of Rs 24.04 crore during the previous quarter ended December 2022. Sales declined 0.50% to Rs 385.89 crore in the quarter ended December 2023 as against Rs 387.84 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales385.89387.84 -1 OPM %6.0512.83 - PBDT10.8547.97 -77 PBT-9.7331.79 PL NP-11.7924.04 PL Powered by Capital Market - Live News

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 9 February 2024.Powered by Capital Market - Live News